NetCE - Continuing Education Online
Home About NetCE Staff & Faculty  Contact  Us 
Read course content

Course # 35110 • Clinical Use of Neuromuscular Blocking Agents


Objective:
Discuss the reversal agent sugammadex.

29. Sugammadex was designed to have a specific affinity for
A) pancuronium.
B) succinylcholine.
C) rocuronium and vecuronium.
D) atracurium and cisatracurium.